Furthermore, we confirmed the correlation of NECTIN4 CNVs, mRNA, and protein expression in a The Cancer Genome Atlas (TCGA) pan-cancer analysis and explored the prevalence of NECTIN4 CNVs representing a potential tumor-agnostic genomic biomarker to predict EV response in multiple cancer entities. This evidence concerns the gene NECTIN4 and neoplasm.